Keda Yu

24PUBLICATIONS

46CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer cell biologyOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jun 16, 2026

A fusion-deletion genomic-event underlies poor prognosis in young patients with luminal breast cancer.

|Jan 13, 2026

Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph Nodes.

Linhui Zhai, Cui-Cui Liu, Lei Zhao

|Apr 14, 2025

SNX10 deficiency impairs sensitivity to anti-HER2 antibody-drug conjugates via altering HER2 trafficking in HER2-positive breast cancer.

Yu-Fei Chen, Qing-Hua Zhang, Zhong-Wei Zhang

|Feb 24, 2025

Circulating Tumor Microenvironment in Metastasis.

Rui Tang, Shujuan Luo, Hui Liu

|Feb 18, 2025

Breast cancer: pathogenesis and treatments.

Xin Xiong, Le-Wei Zheng, Yu Ding

|Jan 04, 2025

A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST study.

Li Chen, Wen-Ya Wu, Fei Liang

Pageof 4

Frequent Collaborators

Zhi-Ming Shao

Haojun Luo

Zhi-Ming Shao

Sufyan Suleman

Huai-Dong Cheng

Xi Jin

Xiao-En Xu

Guo-Hong Hu

Guobing Yin

Da-Qiang Li

Frequent Collaborators

Zhi-Ming Shao

Haojun Luo

Zhi-Ming Shao

Sufyan Suleman